The development and use of anti-VEGF medications such as bevacizumab, ranibizumab and aflibercept have generated an impressive amount of research since this drugs can stop the growth of the abnormal vessels generated from the vascular endothelial growth factor (VEGF) encountered in wet AMD or DR. The gene discussed is VEGFA; the disease is wet macular degeneration.